ClinConnect ClinConnect Logo
Search / Trial NCT06481514

FRI a Method of Reading Cardiotocography (CTG) in Labor

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jun 25, 2024

Trial Information

Current as of July 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new method called the Fetal Reserve Index (FRI) to help doctors read heart rate patterns of babies during labor, known as cardiotocography (CTG). The goal is to see if using FRI can better identify situations where urgent medical help is needed, which could lead to problems for the baby, compared to the usual way of interpreting CTG.

To participate in the trial, women who are in active labor and have had a normal initial heart rate test but later show concerning heart rate patterns may be eligible. Participants will be randomly assigned to either the FRI group, where doctors will use this new method, or to a control group that follows standard care. Women who have had previous C-sections, are pregnant with twins, or have certain health conditions may not be able to join. If you decide to participate, you will need to sign a consent form, and your safety and comfort will be a priority throughout the trial.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women in the active phase of labor who presented when they entered the room I delivered a negative admission test (i.e. a normoreactive CTG according to ACOG) and that subsequently present during labor a diagnosis of category II CTG
  • Single term pregnancy
  • Signature of informed consent
  • Exclusion criteria
  • Failure to sign the informed consent
  • Previous caesarean section (TOLAC)
  • Twin pregnancy
  • Gestational age \<37 weeks
  • Known genetic/chromosomal syndromes and/or malformations, excluding heart disease without contraindication to vaginal birth
  • Exclusion Criteria:
  • -

About Fondazione Policlinico Universitario Agostino Gemelli Irccs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.

Locations

Roma, , Italy

Patients applied

0 patients applied

Trial Officials

Angela BOTTA

Principal Investigator

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported